10 20 30 40 50 60 70 80 2AL5 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER MEMBRANE PROTEIN 04-AUG-05 2AL5
TITLE CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) TITLE 2 IN COMPLEX WITH FLUORO-WILLARDIINE AND ANIRACETAM
COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING CORE (S1S2J); COMPND 5 SYNONYM: GLUR-2, GLUR-B, GLUR-K2, GLUTAMATE RECEPTOR COMPND 6 IONOTROPIC, AMPA 2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: GRIA2, GLUR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETGQ
KEYWDS IONOTROPIC GLUTAMATE RECEPTOR, GLUR2, LIGAND BINDING CORE, KEYWDS 2 S1S2, FLUORO-WILLARDIINE, ANIRACETAM, MODULATOR, MEMBRANE KEYWDS 3 PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR R.JIN,S.CLARK,A.M.WEEKS,J.T.DUDMAN,E.GOUAUX,K.M.PARTIN
REVDAT 2 24-FEB-09 2AL5 1 VERSN REVDAT 1 25-OCT-05 2AL5 0
JRNL AUTH R.JIN,S.CLARK,A.M.WEEKS,J.T.DUDMAN,E.GOUAUX, JRNL AUTH 2 K.M.PARTIN JRNL TITL MECHANISM OF POSITIVE ALLOSTERIC MODULATORS ACTING JRNL TITL 2 ON AMPA RECEPTORS. JRNL REF J.NEUROSCI. V. 25 9027 2005 JRNL REFN ISSN 0270-6474 JRNL PMID 16192394 JRNL DOI 10.1523/JNEUROSCI.2567-05.2005
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.JIN,T.G.BANKE,M.L.MAYER,S.F.TRAYNELIS,E.GOUAUX REMARK 1 TITL STRUCTURAL BASIS FOR PARTIAL AGONIST ACTION AT REMARK 1 TITL 2 IONOTROPIC GLUTAMATE RECEPTORS. REMARK 1 REF NAT.NEUROSCI. V. 6 803 2003 REMARK 1 REFN ISSN 1097-6256 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.SUN,R.OLSON,M.HORNING,N.ARMSTRONG,M.MAYER, REMARK 1 AUTH 2 E.GOUAUX REMARK 1 TITL MECHANISM OF GLUTAMATE RECEPTOR DESENSITIZATION. REMARK 1 REF NATURE V. 417 245 2002 REMARK 1 REFN ISSN 0028-0836
REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1572353.290 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.7 REMARK 3 NUMBER OF REFLECTIONS : 66996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 6824 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7792 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 862 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4016 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 711 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.49000 REMARK 3 B22 (A**2) : 2.44000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.94000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.82 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.120 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.700 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.060 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.060 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 46.15 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : ANI_2.PARA REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : ANI_2.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2AL5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-AUG-05. REMARK 100 THE RCSB ID CODE IS RCSB034023.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70497 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.6 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1MQI REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12-14% PEG 8000, 0.25-0.35 M REMARK 280 AMMONIUM SULFATE AND 0.1 M SODIUM CITRATE, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.06300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ALA A 2 REMARK 465 SER A 263 REMARK 465 GLY B 1 REMARK 465 ALA B 2 REMARK 465 SER B 263
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 LYS A 151 CG CD CE NZ REMARK 470 ARG A 172 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 183 CG CD CE NZ REMARK 470 LYS B 21 CG CD CE NZ REMARK 470 LYS B 50 CG CD CE NZ REMARK 470 LYS B 151 CG CD CE NZ REMARK 470 ARG B 172 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 183 CG CD CE NZ
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 205 23.28 -77.95 REMARK 500 PRO B 205 22.98 -78.03 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1042 DISTANCE = 5.17 ANGSTROMS REMARK 525 HOH A1212 DISTANCE = 5.04 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FWD A 901 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FWD B 902 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4MP A 801
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MQI RELATED DB: PDB REMARK 900 GLUR2 LIGAND BINDING CORE IN COMPLEX WITH FLUORO- REMARK 900 WILLARDIINE. REMARK 900 RELATED ID: 1LBC RELATED DB: PDB REMARK 900 GLUR2 LIGAND BINDING CORE IN COMPLEX WITH GLUTAMATE AND REMARK 900 CYCLOTHIAZIDE REMARK 900 RELATED ID: 2AL4 RELATED DB: PDB
REMARK 999 REMARK 999 SEQUENCE THE NATIVE GLUR2 IS A MEMBRANE PROTEIN. TRANSMEMBRANE REMARK 999 REGIONS WERE GENETICALLY REMOVED AND REPLACED WITH A GLY-THR REMARK 999 LINKER.
DBREF 2AL5 A 3 117 UNP P19491 GLR2_RAT 413 527 DBREF 2AL5 B 3 117 UNP P19491 GLR2_RAT 413 527 DBREF 2AL5 A 120 263 UNP P19491 GLR2_RAT 653 796 DBREF 2AL5 B 120 263 UNP P19491 GLR2_RAT 653 796
SEQADV 2AL5 GLY A 1 UNP P19491 CLONING ARTIFACT SEQADV 2AL5 ALA A 2 UNP P19491 CLONING ARTIFACT SEQADV 2AL5 GLY A 118 UNP P19491 SEE REMARK 999 SEQADV 2AL5 THR A 119 UNP P19491 SEE REMARK 999 SEQADV 2AL5 GLY B 1 UNP P19491 CLONING ARTIFACT SEQADV 2AL5 ALA B 2 UNP P19491 CLONING ARTIFACT SEQADV 2AL5 GLY B 118 UNP P19491 SEE REMARK 999 SEQADV 2AL5 THR B 119 UNP P19491 SEE REMARK 999
SEQRES 1 A 263 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 A 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 A 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 A 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 A 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 A 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 A 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 A 263 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 A 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 A 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 A 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 A 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 A 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 A 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 A 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 A 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 A 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 A 263 ILE ALA THR PRO LYS GLY SER SER LEU GLY ASN ALA VAL SEQRES 19 A 263 ASN LEU ALA VAL LEU LYS LEU ASN GLU GLN GLY LEU LEU SEQRES 20 A 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 A 263 CYS GLY SER SEQRES 1 B 263 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 B 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 B 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 B 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 B 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 B 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 B 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 B 263 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 B 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 B 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 B 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 B 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 B 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 B 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 B 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 B 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 B 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 B 263 ILE ALA THR PRO LYS GLY SER SER LEU GLY ASN ALA VAL SEQRES 19 B 263 ASN LEU ALA VAL LEU LYS LEU ASN GLU GLN GLY LEU LEU SEQRES 20 B 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 B 263 CYS GLY SER
HET FWD A 901 15 HET FWD B 902 15 HET 4MP A 801 32
HETNAM FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H- HETNAM 2 FWD PYRIMIDIN-1-YL)-PROPIONIC ACID HETNAM 4MP 1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE
HETSYN FWD FLUORO-WILLARDIINE HETSYN 4MP ANIRACETAM, 1-P-ANISOYL-2-PYRROLIDINONE
FORMUL 3 FWD 2(C7 H8 F N3 O4) FORMUL 5 4MP C12 H13 N O3 FORMUL 6 HOH *711(H2 O)
HELIX 1 1 ASN A 22 LEU A 26 5 5 HELIX 2 2 GLU A 27 GLU A 30 5 4 HELIX 3 3 GLY A 34 GLY A 48 1 15 HELIX 4 4 ASN A 72 TYR A 80 1 9 HELIX 5 5 THR A 93 GLU A 98 1 6 HELIX 6 6 SER A 123 LYS A 129 1 7 HELIX 7 7 GLY A 141 SER A 150 1 10 HELIX 8 8 ILE A 152 ALA A 165 1 14 HELIX 9 9 THR A 173 SER A 184 1 12 HELIX 10 10 SER A 194 GLU A 201 1 8 HELIX 11 11 LEU A 230 GLN A 244 1 15 HELIX 12 12 GLY A 245 TYR A 256 1 12 HELIX 13 13 ASN B 22 LEU B 26 5 5 HELIX 14 14 GLU B 27 GLU B 30 5 4 HELIX 15 15 GLY B 34 GLY B 48 1 15 HELIX 16 16 ASN B 72 TYR B 80 1 9 HELIX 17 17 THR B 93 GLU B 98 1 6 HELIX 18 18 SER B 123 LYS B 129 1 7 HELIX 19 19 GLY B 141 SER B 150 1 10 HELIX 20 20 ILE B 152 ALA B 165 1 14 HELIX 21 21 THR B 173 SER B 184 1 12 HELIX 22 22 SER B 194 GLU B 201 1 8 HELIX 23 23 LEU B 230 GLN B 244 1 15 HELIX 24 24 GLY B 245 TYR B 256 1 12
SHEET 1 A 3 TYR A 51 ILE A 55 0 SHEET 2 A 3 VAL A 6 THR A 10 1 N VAL A 8 O LYS A 52 SHEET 3 A 3 ILE A 85 ALA A 86 1 O ILE A 85 N THR A 9 SHEET 1 B 2 MET A 18 MET A 19 0 SHEET 2 B 2 TYR A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 C 2 ILE A 100 PHE A 102 0 SHEET 2 C 2 ALA A 223 PRO A 225 -1 O THR A 224 N ASP A 101 SHEET 1 D 2 MET A 107 LEU A 109 0 SHEET 2 D 2 LYS A 218 TYR A 220 -1 O LYS A 218 N LEU A 109 SHEET 1 E 4 ALA A 134 GLY A 136 0 SHEET 2 E 4 TYR A 188 GLU A 193 1 O LEU A 191 N GLY A 136 SHEET 3 E 4 ILE A 111 LYS A 116 -1 N MET A 114 O TYR A 190 SHEET 4 E 4 THR A 208 VAL A 211 -1 O MET A 209 N ILE A 115 SHEET 1 F 3 TYR B 51 ILE B 55 0 SHEET 2 F 3 VAL B 6 THR B 10 1 N VAL B 8 O LYS B 52 SHEET 3 F 3 ILE B 85 ALA B 86 1 O ILE B 85 N THR B 9 SHEET 1 G 2 MET B 18 MET B 19 0 SHEET 2 G 2 TYR B 32 GLU B 33 -1 O GLU B 33 N MET B 18 SHEET 1 H 2 ILE B 100 PHE B 102 0 SHEET 2 H 2 ALA B 223 PRO B 225 -1 O THR B 224 N ASP B 101 SHEET 1 I 2 MET B 107 LEU B 109 0 SHEET 2 I 2 LYS B 218 TYR B 220 -1 O LYS B 218 N LEU B 109 SHEET 1 J 4 ALA B 134 GLY B 136 0 SHEET 2 J 4 TYR B 188 GLU B 193 1 O LEU B 191 N GLY B 136 SHEET 3 J 4 ILE B 111 LYS B 116 -1 N MET B 114 O TYR B 190 SHEET 4 J 4 THR B 208 VAL B 211 -1 O MET B 209 N ILE B 115
SSBOND 1 CYS A 206 CYS A 261 1555 1555 2.03 SSBOND 2 CYS B 206 CYS B 261 1555 1555 2.03
CISPEP 1 SER A 14 PRO A 15 0 -0.08 CISPEP 2 GLU A 166 PRO A 167 0 0.06 CISPEP 3 LYS A 204 PRO A 205 0 0.35 CISPEP 4 SER B 14 PRO B 15 0 -0.03 CISPEP 5 GLU B 166 PRO B 167 0 0.14 CISPEP 6 LYS B 204 PRO B 205 0 0.42
SITE 1 AC1 16 TYR A 61 PRO A 89 LEU A 90 THR A 91 SITE 2 AC1 16 ARG A 96 LEU A 138 GLY A 141 SER A 142 SITE 3 AC1 16 THR A 143 THR A 174 LEU A 192 GLU A 193 SITE 4 AC1 16 MET A 196 HOH A 905 HOH A 909 HOH A 977 SITE 1 AC2 16 TYR B 61 PRO B 89 LEU B 90 THR B 91 SITE 2 AC2 16 ARG B 96 LEU B 138 GLY B 141 SER B 142 SITE 3 AC2 16 THR B 143 THR B 174 LEU B 192 GLU B 193 SITE 4 AC2 16 MET B 196 HOH B 905 HOH B 909 HOH B 987 SITE 1 AC3 15 PRO A 105 SER A 108 SER A 217 LYS A 218 SITE 2 AC3 15 GLY A 219 ASN A 242 HOH A 936 HOH A1146 SITE 3 AC3 15 HOH A1153 PRO B 105 SER B 108 SER B 217 SITE 4 AC3 15 LYS B 218 ASN B 242 HOH B1112
CRYST1 48.056 64.126 107.949 90.00 90.07 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020809 0.000000 0.000025 0.00000
SCALE2 0.000000 0.015594 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009264 0.00000